Published in
American Association for the Advancement of Science, Science Translational Medicine, 513(11), 2019
DOI: 10.1126/scitranslmed.aay2574
Links
Tools
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
Journal article published in 2019 by
Salo N. Ooft 
,
Fleur Weeber ,
Krijn K. Dijkstra ,
Chelsea M. McLean ,
Sovann Kaing,
Erik van Werkhoven ,
Luuk Schipper,
Louisa Hoes,
Daniel J. Vis,
Joris van de Haar ,
Warner Prevoo,
Petur Snaebjornsson ,
Daphne van der Velden ,
Michelle Klein ,
Myriam Chalabi
and other authors.
,
Fleur Weeber ,
Krijn K. Dijkstra ,
Chelsea M. McLean ,
Sovann Kaing,
Erik van Werkhoven ,
Luuk Schipper,
Louisa Hoes,
Daniel J. Vis,
Joris van de Haar ,
Warner Prevoo,
Petur Snaebjornsson ,
Daphne van der Velden ,
Michelle Klein ,
Myriam Chalabi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Tumor organoids from individual patients with metastatic colorectal cancer can help predict response to irinotecan with or without 5-fluorouracil.